These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21796580)

  • 1. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
    Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
    Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
    [No Abstract]   [Full Text] [Related]  

  • 2. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
    Bassotti G; Usai Satta P; Bellini M
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 6. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
    Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride: a new drug for the treatment of chronic constipation.
    Tack J
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride: For functional constipation only?
    Bellini M; Gambaccini D; Bassotti G
    Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminal 5-HT
    Gwynne RM; Bornstein JC
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13708. PubMed ID: 31524331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
    Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
    J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
    Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
    Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. prucalopride (Resolor°) and chronic constipation in men: Avoid in both men and women.
    Prescrire Int; 2016 Oct; 25(175):234. PubMed ID: 30645825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prucalopride (Motegrity) for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):86-88. PubMed ID: 31170120
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride in a case of severe opioid induced constipation.
    Dagtekin O
    Minerva Anestesiol; 2012 Apr; 78(4):513-4. PubMed ID: 22310195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.